(Q81535280)
Statements
Pathologic complete response to trastuzumab-based neoadjuvant therapy is related to the level of HER-2 amplification (English)
Laurent Arnould
Patrick Arveux
Jerome Couturier
Marion Gelly-Marty
Catherine Loustalot
Francette Ettore
Christine Sagan
Martine Antoine
Frederique Penault-Llorca
Berangere Vasseur
Pierre Fumoleau
1 November 2007